US 10570140
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted A61KA61K31/7064A61P
Quick answer
US patent 10570140 (Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)) held by Prelude Therapeutics, Incorporated expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prelude Therapeutics, Incorporated
- Grant date
- Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/7064, A61P, A61P35/02